Paul, R. K., Singh, N. S., Khadeer, M., Moaddel, R., Sanghvi, M., Green, C. E., . . . Wainer, I. W. (2014). (R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin (mTOR) function.
シカゴスタイル引用形Paul, Rajib K., et al. (R,S)-Ketamine Metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine Increase the Mammalian Target of Rapamycin (mTOR) Function. 2014.
MLA引用形式Paul, Rajib K., et al. (R,S)-Ketamine Metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine Increase the Mammalian Target of Rapamycin (mTOR) Function. 2014.
警告: この引用は必ずしも正確ではありません.